Brendan B McCormick

Summary

Affiliation: University of Ottawa
Country: Canada

Publications

  1. ncbi Severe hypocalcemia following denosumab injection in a hemodialysis patient
    Brendan B McCormick
    Division of Nephrology, Department of Medicine, University of Ottawa, Ontario, Canada
    Am J Kidney Dis 60:626-8. 2012
  2. ncbi Metabolic effects of incremental doses of intraperitoneal amino acids on automated peritoneal dialysis
    Brendan B McCormick
    Division of Nephrology, Department of Medicine, The University of Ottawa, Ottawa, Ontario, Canada
    Perit Dial Int 30:201-7. 2010
  3. ncbi The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis
    Brendan B McCormick
    Division of Nephrology, Kidney Research Center, Ottawa Health Research Institute, Ottawa, Ontario, Canada
    Am J Kidney Dis 52:454-63. 2008
  4. ncbi Noninfectious complications of peritoneal dialysis: implications for patient and technique survival
    Brendan B McCormick
    Division of Nephrology, Kidney Research Center, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    J Am Soc Nephrol 18:3023-5. 2007
  5. ncbi Complications and catheter survival with prolonged embedding of peritoneal dialysis catheters
    Pierre Antoine Brown
    Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Nephrol Dial Transplant 23:2299-303. 2008
  6. ncbi Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics
    Sunil V Badve
    Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Clin J Am Soc Nephrol 3:1711-7. 2008
  7. ncbi Review of clinical outcomes in nocturnal haemodialysis patients after renal transplantation
    Brendan B McCormick
    Division of Nephrology, Toronto General Hospital, University of Toronto, Ontario, Canada
    Nephrol Dial Transplant 19:714-9. 2004
  8. ncbi Spironolactone for difficult to control hypertension in chronic kidney disease: an analysis of safety and efficacy
    Jodi Heshka
    Department of Medicine, University of Ottawa, Ottawa, Ontario
    J Am Soc Hypertens 4:295-301. 2010
  9. ncbi The implications of the ADEMEX study for the peritoneal dialysis prescription: the role of small solute clearance versus salt and water removal
    Brendan B McCormick
    Toronto General Hospital, Ontario, Canada
    Curr Opin Nephrol Hypertens 12:581-5. 2003
  10. ncbi A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis
    Lily Oliveira
    Department of Medicine, Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada
    Ther Apher Dial 11:227-31. 2007

Collaborators

Detail Information

Publications13

  1. ncbi Severe hypocalcemia following denosumab injection in a hemodialysis patient
    Brendan B McCormick
    Division of Nephrology, Department of Medicine, University of Ottawa, Ontario, Canada
    Am J Kidney Dis 60:626-8. 2012
    ..We advise against the use of denosumab in those treated with hemodialysis due to the risk of severe hypocalcemia and lack of evidence supporting its efficacy in treating osteoporosis in this population...
  2. ncbi Metabolic effects of incremental doses of intraperitoneal amino acids on automated peritoneal dialysis
    Brendan B McCormick
    Division of Nephrology, Department of Medicine, The University of Ottawa, Ottawa, Ontario, Canada
    Perit Dial Int 30:201-7. 2010
    ..The use of amino acid (AA) dialysate to ameliorate protein-energy malnutrition has been limited by adverse metabolic effects...
  3. ncbi The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis
    Brendan B McCormick
    Division of Nephrology, Kidney Research Center, Ottawa Health Research Institute, Ottawa, Ontario, Canada
    Am J Kidney Dis 52:454-63. 2008
    ..Pentoxifylline is a potential therapeutic agent for diabetic kidney disease because it has anti-inflammatory, antifibrotic, and hemorheological properties...
  4. ncbi Noninfectious complications of peritoneal dialysis: implications for patient and technique survival
    Brendan B McCormick
    Division of Nephrology, Kidney Research Center, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    J Am Soc Nephrol 18:3023-5. 2007
    ..This clinical commentary focuses on these noninfectious complications of PD...
  5. ncbi Complications and catheter survival with prolonged embedding of peritoneal dialysis catheters
    Pierre Antoine Brown
    Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Nephrol Dial Transplant 23:2299-303. 2008
    ..We undertook this study to test the hypothesis that catheter survival on PD is a function of the time a catheter is left embedded prior to use...
  6. ncbi Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics
    Sunil V Badve
    Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Clin J Am Soc Nephrol 3:1711-7. 2008
    ..The objective of this study was to test the hypothesis that peritoneal phosphate clearance is better with continuous ambulatory PD (CAPD) as compared with continuous cyclic PD (CCPD) after adjusting for membrane transport status...
  7. ncbi Review of clinical outcomes in nocturnal haemodialysis patients after renal transplantation
    Brendan B McCormick
    Division of Nephrology, Toronto General Hospital, University of Toronto, Ontario, Canada
    Nephrol Dial Transplant 19:714-9. 2004
    ..Further prospective studies are needed to examine the underlying differences in haemodynamics and long-term graft survival between the two renal replacement modalities...
  8. ncbi Spironolactone for difficult to control hypertension in chronic kidney disease: an analysis of safety and efficacy
    Jodi Heshka
    Department of Medicine, University of Ottawa, Ottawa, Ontario
    J Am Soc Hypertens 4:295-301. 2010
    ..It is associated with a modest rise in serum potassium, which is more pronounced among those with glomerular filtration rate below 45 mL/minute...
  9. ncbi The implications of the ADEMEX study for the peritoneal dialysis prescription: the role of small solute clearance versus salt and water removal
    Brendan B McCormick
    Toronto General Hospital, Ontario, Canada
    Curr Opin Nephrol Hypertens 12:581-5. 2003
    ..This has resulted in de-emphasis of peritoneal small molecule clearance and increased emphasis on clinical assessment of dialysis adequacy, preservation of residual renal function, and optimization of salt and water removal...
  10. ncbi A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis
    Lily Oliveira
    Department of Medicine, Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada
    Ther Apher Dial 11:227-31. 2007
    ..This is the first report of late rescue from apparent ESRD due to FSGS with combined plasmapheresis and low dose oral cyclophosphamide...
  11. ncbi Extracorporeal management of valproic acid overdose: a large regional experience
    Sheldon M Singh
    Division of Nephrology, Department of Medicine, University of Toronto, ON, Canada
    J Nephrol 17:43-9. 2004
    ..Further study is needed to determine whether hemodialysis alone versus combined hemodialysis-hemoperfusion is more effective for this condition...
  12. ncbi Peritoneal dialysis catheter insertion strategies and maintenance of catheter function
    Nasim Shahbazi
    Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada
    Semin Nephrol 31:138-51. 2011
    ..Maintenance of catheter function is discussed with a focus on an organized and evidence-based approach to preventing and treating mechanical catheter problems...
  13. ncbi Improved blood pressure control with nocturnal hemodialysis: review of clinical observations and physiologic mechanisms
    Brendan B McCormick
    Toronto General Hospital, University Health Network, 200 Elizabeth Street, 12 EN 226, Toronto, Ontario, Canada M5G 2C4
    Curr Hypertens Rep 6:140-4. 2004
    ..Recent mechanistic studies exploring the reversal of the uremic hemodynamic state with NHD are also reviewed. The implication of these hemodynamic changes for the prospective renal transplant candidate are discussed...